EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Combining Cyproheptadine Hydrochloride With Targeted Muscle Activation Training to Treat Upper Extremity Stroke: A Randomized, Placebo-Controlled Trial

Derek Kamper, Naveen Bansal, Alexander Barry, Na Jin Seo, Courtney Celian, Lynn Vidakovic, Mary Ellen Stoykov, Elliot Roth

Archives of Physical Medicine and Rehabilitation · 2024

DOI: 10.1016/j.apmr.2024.06.022 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Archives of Physical Medicine and Rehabilitation, 2024. Verfasst von Derek Kamper und 7 weiteren Autor:innen. Beteiligte Einrichtung: Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC; Joint Department of Biomedical Engineering,…. Hauptthemen laut MEDLINE: Cyproheptadine, Stroke Rehabilitation, Upper Extremity, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: NICHD NIH HHS, National Institutes of Health, National Institute on Disability, Independent Living, and Rehabilitation Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To examine a treatment for upper extremity impairment in stroke survivors that combines administration of cyproheptadine hydrochloride with repetitive practice focused on control of muscle activation patterns. DESIGN: Double-blind, randomized controlled trial. SETTINGS: Laboratory within a free-standing rehabilitation hospital. PARTICIPANTS: A total of 94 stroke survivors with severe, chronic hand impairment were randomly assigned to 1 of 4 treatment groups. INTERVENTIONS: Participants received either a placebo or cyproheptadine hydrochloride in identical pill form. The daily dosage of cyproheptadine/placebo was gradually increased from 8 to 24 mg/d over 3 weeks and then maintained over the next 6 weeks while participants completed 18 therapy sessions. Therapy consisted of either (1) active practice of muscle activation patterns to play "serious" computer games or control a custom hand exoskeleton or (2) passive, cyclical finger stretching imposed by the exoskeleton. MAIN OUTCOME MEASURES: Hand control was evaluated with the primary outcome measure of time to complete the Graded Wolf Motor Function Test (GWMFT) and secondary outcome measures including finger strength and spasticity. RESULTS: Across the 88 participants who completed the study, a repeated-measures analysis of variance revealed a significant effect of GroupxEvaluation interaction on GWMFT (F=1.996, P=.026). The 3 groups receiving cyproheptadine and/or actively practicing muscle activation pattern control exhibited significant reduction in mean time to complete the GWMFT tasks; roughly one-third of these participants experienced at least a 10% reduction in completion time. Gains were maintained at the 1-month follow-up evaluation. The group receiving placebo and passive stretching did not show improvement. No significant differences among groups were observed in terms of changes in strength or spasticity. CONCLUSIONS: Despite chronic, severe impairment, stroke survivors were able to complete the therapy focused on muscle activations and achieved statistically significant improvement in hand motor control. Cyproheptadine hydrochloride is a potential complementary treatment modality for stroke survivors with hand impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyproheptadineStroke RehabilitationUpper ExtremityStrokeHumansMaleFemaleDouble-Blind MethodMiddle AgedAgedCombined Modality TherapyAdultMuscle SpasticityTreatment OutcomeMuscle Stretching Exercises

Stichwörter der Autor:innen

Drug therapyHandMuscle activation patternsRehabilitationStroke

Substanzen

Cyproheptadine

Autor:innen und Institutionen

  • Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC; Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, NC. Electronic address: dgk…
  • Department of Mathematical and Statistical Sciences, Marquette University, Milwaukee, WI.
  • Shirley Ryan AbilityLab, Chicago, IL.
  • Department of Rehabilitation Sciences, Medical University of South Carolina, Charleston, SC.
  • Froedert & Medical College of Wisconsin, Milwaukee, WI.
  • Shirley Ryan AbilityLab, Chicago, IL; Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL.

Förderung

  • NICHD NIH HHS
  • National Institutes of Health
  • National Institute on Disability, Independent Living, and Rehabilitation Research
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Northwestern University
  • Eidgenössische Technische Hochschule Zürich
  • National Center for Medical Rehabilitation Research

Zitieren

APA

Kamper, D., Bansal, N., Barry, A., Seo, N. J., Celian, C., Vidakovic, L., Stoykov, M. E., & Roth, E. (2024). Combining Cyproheptadine Hydrochloride With Targeted Muscle Activation Training to Treat Upper Extremity Stroke: A Randomized, Placebo-Controlled Trial. Archives of Physical Medicine and Rehabilitation. https://doi.org/10.1016/j.apmr.2024.06.022

Vancouver

Kamper D, Bansal N, Barry A, Seo NJ, Celian C, Vidakovic L, et al. Combining Cyproheptadine Hydrochloride With Targeted Muscle Activation Training to Treat Upper Extremity Stroke: A Randomized, Placebo-Controlled Trial. Archives of Physical Medicine and Rehabilitation. 2024. doi:10.1016/j.apmr.2024.06.022

BibTeX
@article{Kamper2024,
  author = {Kamper, Derek and Bansal, Naveen and Barry, Alexander and Seo, Na Jin and Celian, Courtney and Vidakovic, Lynn and Stoykov, Mary Ellen and Roth, Elliot},
  title = {Combining Cyproheptadine Hydrochloride With Targeted Muscle Activation Training to Treat Upper Extremity Stroke: A Randomized, Placebo-Controlled Trial},
  journal = {Archives of Physical Medicine and Rehabilitation},
  year = {2024},
  doi = {10.1016/j.apmr.2024.06.022}
}
Kostenlos starten →